Acute myeloid leukemia (AML) - Type chemotherapy for newly diagnosed children with myelodysplastic syndrome (MDS): A Japanese childhood MDS study group trial MDS99.

被引：0
|
作者：
Ohtsuka, Y [1 ]
Manabe, A [1 ]
Okamura, J [1 ]
Kojima, S [1 ]
Ohara, A [1 ]
Tuchida, M [1 ]
Ikuta, K [1 ]
Hibi, S [1 ]
Kawa, K [1 ]
Yabe, M [1 ]
Watanabe, A [1 ]
Ueda, K [1 ]
Nakazawa, S [1 ]
Miyazaki, S [1 ]
Nakahata, T [1 ]
机构：
[1] Hyogo Med Univ, Dept Pediat, Nishinomiya, Hyogo, Japan
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4726
引用
收藏
页码：265B / 265B
页数：1
相关论文
共 50 条
  • [1] CONNECT MDS AND AML: THE MYELODYSPLASTIC SYNDROMES (MDS) AND ACUTE MYELOID LEUKEMIA (AML) DISEASE REGISTRY
    Steensma, D.
    Abedi, M.
    Bejar, R.
    Cogle, C.
    Foucar, K.
    Garcia-Manero, G.
    George, T.
    Grinblatt, D.
    Komrokji, R.
    Maciejewski, J.
    Pollyea, D.
    Roboz, G.
    Savona, M.
    Scott, B.
    Sekeres, M.
    Thompson, M.
    Sugrue, M.
    Swern, A.
    Nifenecker, M.
    Erba, H.
    LEUKEMIA RESEARCH, 2015, 39 : S124 - S124
  • [2] Symptom Burden In Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
    Williams, Loretta A.
    Ault, Patricia S.
    Kantarjian, Hagop M.
    Garcia-Manero, Guillermo
    Quintas-Cardama, Alfonso
    Borthakur, Gautam
    Faderl, Stefan H.
    Jabbour, Elias J.
    Cleeland, Charles S.
    Cortes, Jorge E.
    BLOOD, 2013, 122 (21)
  • [3] Treatment of Children With Refractory Anemia: The Japanese Childhood MDS Study Group Trial (MDS99)
    Hasegawa, Daisuke
    Manabe, Atsushi
    Yagasaki, Hiroshi
    Ohtsuka, Yoshitoshi
    Inoue, Masami
    Kikuchi, Akira
    Ohara, Akira
    Tsuchida, Masahiro
    Kojima, Seiji
    Nakahata, Tatsutoshi
    PEDIATRIC BLOOD & CANCER, 2009, 53 (06) : 1011 - 1015
  • [4] Acute myelogenous leukemia (AML) type induction chemotherapy for the patients with myelodysplastic syndrome (MDS)
    Kim, D.-Y.
    Kim, J.-S.
    Kim, B.-S.
    Bang, S.-M.
    Kim, I.
    Yoon, S.-S.
    Park, S.
    Kim, B. K.
    LEUKEMIA RESEARCH, 2007, 31 : S138 - S138
  • [5] Homoharringtonine in patients with myelodysplastic syndrome (MDS) and MDS evolving to acute myeloid leukemia
    Feldman, EJ
    Seiter, KP
    Ahmed, T
    Baskind, P
    Arlin, ZA
    LEUKEMIA, 1996, 10 (01) : 40 - 42
  • [6] CONCOMITANT MONOCLONAL GAMMOPATHY OF UNKNOWN SIGNIFICANCE (MGUS) IN NEWLY DIAGNOSED MYELODYSPLASTIC SYNDROME/ACUTE MYELOID LEUKEMIA (MDS/AML)
    Chen, Mingyi
    La, Hanh
    Abedi, Mehrdad
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2014, 36 : 47 - 48
  • [7] Treatment Results of Intensive Chemotherapy for Higher-Risk Myelodysplastic Syndrome (HR-MDS) and Acute Myeloid Leukemia Related to MDS (MDS-AML)
    Kyo, Taiichi
    Yoshida, Noriaki
    Kyo, Kouhei
    Okatani, Takeshi
    Itagaki, Mitsuhiro
    Yuasa, Hiromi
    Iwato, Koji
    Asaoku, Hideki
    Katayama, Yuuta
    BLOOD, 2010, 116 (21) : 1209 - 1210
  • [8] Diagnostic of myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML)
    Germing, Ulrich
    Haferlach, Torsten
    LABORATORIUMSMEDIZIN-JOURNAL OF LABORATORY MEDICINE, 2015, 39 (05): : 291 - 299
  • [9] Comparison of Symptom Burden in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
    Williams, Loretta A.
    Ahaneku, Hycienth
    Cortes, Jorge E.
    Manero, Guillermo Garcia
    Kantarjian, Hagop M.
    Shi, Qiuling
    Lin, Huei-Kai
    Limaye, Achala R.
    Cleeland, Charles S.
    BLOOD, 2014, 124 (21)
  • [10] Myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) in Down syndrome: Pathologic aspects
    Mast, K.
    Taub, J. W.
    Alonzo, T.
    Mosse, C.
    Gamis, A. S.
    Mathew, P.
    Jones, H.
    Hitzler, J.
    Head, D. R.
    LEUKEMIA RESEARCH, 2013, 37 : S89 - S90
12345